Role of incretin based therapies in the treatment of diabetic kidney disease
Diabetic kidney disease (DKD), a serious microvascular complication of diabetes mellitus is a leading cause of end-stage renal disease and is associated with an increased risk of cardiovascular morbidity and mortality. Despite advancements in blood glucose and blood pressure (BP) control, ~20% to 40...
Saved in:
Main Authors: | Paola Fioretto, Andrea Frascati |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/e96ccbff02ea4c3eb6e487f109d992fc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
by: Elena Valer'evna Biryukova
Published: (2014) -
Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
by: Yury Ivanovich Suntsov
Published: (2012) -
The role of incretin-based therapies in the management of type 2 diabetes mellitus: perspectives on the past, present and future
by: Juris J. Meier
Published: (2019) -
Inсretin-based therapy in patients with type 2 diabetes and chronic kidney disease
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2012) -
Expert committee on introduction of incretin-based therapy in Russia: advance and failure
by: Editorial team Diabetes Mellitus
Published: (2012)